Startup Valuation Challenges
The discussion dives into the struggles faced by Roe, a health tech startup that rapidly expanded beyond its original product of erectile dysfunction pills. Despite reaching a valuation of $5 billion, the company has experienced significant employee departures and cultural challenges as it attempts to grow into its ambitious vision. Insights reveal how high valuations and VC incentives can create unrealistic expectations, leading to a cycle of pain for startups.In this clip
From this podcast
Equity
The inherent tensions within Venture capital
Related Questions